Green tea catechins prevent obesity through modulation of peroxisome proliferator-activated receptors by JingQi Yan et al.
SCIENCE CHINA 
Life Sciences 
© The Author(s) 2013. This article is published with open access at Springerlink.com life.scichina.com   www.springer.com/scp 
                  
†Contributed equally to this work 
*Corresponding author (email: zhaobl@sun5.ibp.ac.cn) 
• RESEARCH  PAPER • September 2013  Vol.56  No.9: 804–810 
Progress of Projects Supported by NSFC doi: 10.1007/s11427-013-4512-2 
Green tea catechins prevent obesity through modulation of 
peroxisome proliferator-activated receptors 
YAN JingQi1†, ZHAO Yan2† & ZHAO BaoLu1* 
1State Key Laboratory of Brain & Cognitive Sciences, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; 
2Department of Food Sciences and Technology, Harbin Institute of Technology at Weihai, Weihai 264209, China 
Received March 27, 2013; accepted May 24, 2013; published online July 10, 2013 
 
Epidemiological evidence and experimental studies suggest that drinking green tea is associated with a lower risk of obesity 
and related diseases. However, the mechanisms of these effects are not clear. In the present study, we investigated the anti- 
obesity mechanisms of green tea catechins (GTCs) through modulation of peroxisome proliferator activated-receptor (PPAR) 
pathways in high-fat diet-induced obesity in rats. GTC supplementation significantly attenuated the increased body and liver 
weights and the elevated serum and liver triglyceride levels. Meanwhile, GTCs increased the PPARγ levels in subcutaneous 
white adipose tissue (SWAT) and decreased the PPAR levels in visceral white adipose tissue (VWAT). In addition, GTC 
treatment up-regulated the levels of PPARδ in SWAT, VWAT, and brown adipose tissue and increased the expression of genes 
involved in fatty acid oxidation in brown adipose tissue. Our results suggest that GTCs exert their anti-obesity mechanism in 
part by modulating PPAR signaling pathways. 
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Obesity, a condition that increases the risk of a number of 
chronic diseases such as type 2 diabetes mellitus (T2DM), 
hypertension, hyperlipidemia and cardiovascular disease, 
has rapidly increased worldwide over the last few decades 
[1,2]. Epidemiological studies and experimental data show 
that drinking green tea or administration of its components, 
green tea catechins (GTCs), is associated with a lower risk 
of obesity [3–10]. Moreover, GTCs are involved in modu-
lating fat metabolism [3,5,6,8,11–13], but the mechanisms 
are not clear. 
One family of transcription factors critical to fat metabo-
lism are peroxisome proliferator-activated receptors (PPARs) 
(PPAR , and ), which are ligand-activated transcription 
factors in the nuclear receptor superfamily [14]. Each PPAR 
displays a tissue-selective expression pattern and has a dis-
tinct role in lipid metabolism [15,16]. PPARα, mainly ex-
pressed in liver, possibly mediates the hypotriglyceridemic 
effect of fibrates by inducing mitochondrial and peroxisomal 
-oxidation in liver, kidney, heart, and muscle, and by de-
creasing the plasma concentration of triacylglycerol-rich 
lipoproteins [17]. PPAR is one of the central regulators of 
adipogenesis that promotes lipid storage in adipocytes [15]. 
PPARδ, mainly expressed in brown adipose tissue (BAT) 
and muscle, specifically induces the expression of genes 
required for fatty acid oxidation and energy dissipation, 
which lead to the improvement of lipid profiles and the re-
duction of adiposity [16]. Increasing the levels of PPARδ in 
white adipose tissue (WAT) is suggested as a potential 
strategy to treat obesity [18].  
Green tea components have been shown to affect PPAR 
signaling pathways. Lee et al. [19] reported that green tea 
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and its main component, epigallocatechin gallate (EGCG), 
increased the activation of PPAR. Tea catechins were also 
found to suppress adipocyte differentiation accompanied by 
down-regulation of PPAR and CCAAT-enhancer-binding 
protein (C/EBP) [5]. Moreover, Ashida et al. [4] reported 
that green tea suppressed the expression of PPAR, de-
creased the translocation of glucose transporter 4 (GLUT4), 
and decreased the activation of sterol regulatory element 
binding protein-1 in adipose tissue. Therefore, PPARs may 
be involved in the anti-obesity effects of green tea but no 
clear mechanisms have been proposed. In this study, the 
roles of PPARs and related pathways in the anti-obesity 
mechanisms of GTCs were investigated using a high-fat 
(HF) diet-induced obesity rat model. 
1  Materials and methods 
1.1  Animals 
Male Sprague-Dawley rats, 30 days old weighing 180–200 g, 
were purchased from the Vital Active Company (Beijing, 
China) and were housed in a specific parasite free environ-
ment at 22°C with a 12-h light-dark cycle. All rats were fed 
standard chow diets for 3 d to adapt. Rats were then ran-
domly divided into two groups. One group was fed the reg-
ular chow diet; the other was fed a high-fat diet (15% satu-
rated fat, 1% cholesterol, 84% chow diet). The rats were 
weighed 30 d after starting the diet to determine increases in 
body weight induced by the high-fat diet. Rats fed the 
high-fat (HF) or chow (CHOW) diet were each randomly 
divided into two groups (chow diet groups 1 and 2 and 
high-fat diet groups 1 and 2). Each of the four groups had 
10 rats. Group 1 of the chow diet group and group 1 of the 
high-fat diet were selected as the GTC feeding groups. Rats 
in the GTC feeding groups were gavaged GTCs at 100 mg 
kg1 (body weight) d1. Body weight and food consumption 
of the rats were recorded every day. The rats were sacrificed 
30 or 45 d after GTC feeding, and the liver and adipose tis-
sue were collected and frozen at −75°C. GTCs used in this 
study were 98% pure. They contained 50% ()-epigallo-     
catechin gallate (EGCG), 22% ()-epicatechin gallate (ECG), 
18% )-epigallocatechin (EGC), and 10% ()-epicatechin 
(EC) (analyzed by HPLC). GTCs were provided by 
Fullgreen Biology Technology Co. Ltd. (Mianyang, Si-
chuan, China).  
1.2  Measurement of triglyceride content 
Triglycerides (TGs) were assayed according to Shimabukuro 
et al. [20] with modification. In brief, 50 mg of liver tissue 
was homogenized in 1 mL of lysis buffer with the addition 
of 5% (v/v) Triton X-100 to ensure homogenous lipid dis-
tribution. TG contents were measured using a colorimetric 
assay that quantifies the glycerol contents of the samples 
[20]. Serum TGs were analyzed in a Hitachi 2000 auto-  
analyzer. Protein concentration was measured with a BCA 
assay kit (Pierce, USA). 
1.3  RT-PCR 
Total RNA was extracted from adipose tissues with TRIzol 
Reagent (Invitrogen, USA). The total RNA (2 g) was re-
verse transcribed using SuperScript First-Strand Synthesis 
System (Invitrogen, USA). Primers were designed accord-
ing to the sequences in GenBank as listed in Table 1. 
A standard 25 L PCR with 2 L of the reverse transcrip-
tase was performed using the following parameters: 95°C, 40 
s, annealing temperature, 40 s, 72°C, 45 s, for 27 cycles with 
TaKaRa Ex Taq Hot Start Version (TaKaRa, Japan) in an 
MJ Research PTC-200 Peltier Thermal Cycler. The PCR 
reaction products (10 L) were separated on 2% agarose gels 
by electrophoresis. Densitometric quantification of the band 
intensities was analyzed using NIH Image J software. 
1.4  Western blot 
Rat adipose tissue samples were homogenized in a buffer 
containing 100 mmol L1 NaCl, 10 mmol L1 TrisCl,      
1 mmol L1 EDTA, pH 8.0, 1 g mL1 aprotinin, 100 g 
mL1 phenylmethylsulfonyl fluoride (PMSF), and 10 g 
mL1 leupeptin. Tissue was then centrifuged at 12000×g for 
5 min at 4°C and the supernatants were collected. Protein 
concentrations were determined with a BCA assay kit (Pierce, 
USA). Soluble lysates were subjected to 10% SDS-PAGE.  
Table 1  Primers used for RT-PCRa)s 
Gene Sense primer (5′3′) Anti-sense primer (5′3′) Temperature (°C) GenBank accession No. 
-actin TACAACCTCCTTGCAGCTCC GGATCTTCATGAGGTAGTCAGTC 58 J00691 
AOX GCCCTCAGCTATGGTATTAC AGGAACTGCTCTCACAATGC 63 J02752
CPT1 TATGTGAGGATGCTGCTTCC CTCGGAGAGCTAAGCTTGT 64 L07736 
UCP-1 CTCACCTTTGAGCTCCTC CTGATTTGCCTCTGGATG 58 M11814 
a) AOX, acyl-CoA oxidase; CPT1, carnitine palmitoyltransferase-1; UCP-1, uncoupling protein-1. 
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Proteins were then transferred to nitrocellulose membranes 
and blocked with 5% non-fat milk/TBST for 1 h at room 
temperature. Membranes were incubated with primary an-
tibodies against PPAR (1:500), PPAR : PPAR- 
(1:1000), and -Actin (1:500). The films were scanned and 
densitometry of the immunoblot bands was quantitated us-
ing NIH Image J densitometry software. 
1.5  Thiobarbituric acid reactive substances (TBARS) 
The level of lipid peroxidation of liver was measured by 
determining TBARS. The liver homogenates (50 L) were 
mixed with 1 mL 20% (w/v) trichloroacetic acid, 0.8 mL 
double distilled water, 1 mL 0.67% (w/v) 2-thiobarbituric 
acid, and 0.1 mL 0.2% (w/v) butylated hydroxytoluene. 
After vortexing, the mixtures were incubated for 60 min in 
boiling water. TBARS were extracted with 3 mL of 
n-butanol and centrifuged at 4400×g for 10 min. The ab-
sorption of the butanol layer was then measured at 532 nm. 
Values are expressed in nmol of MDA g1 of wet tissue. In 
the assay, 1,1,3,3-tetraethoxypropane was used as MDA 
standard. 
1.6  Statistics 
Results are presented as means with standard errors. Statis-
tical analysis was performed using ORIGIN. Differences 
between the groups were established using the least signifi-
cant difference (LSD) test. Significance was assessed at the 
P<0.05 level. 
2  Results 
2.1  GTCs have anti-obesity and hypolipidemic effects 
The rats fed a high-fat diet had significantly more weight 
gain than rats fed a chow diet, and GTCs significantly de-
creased body weight (Figure 1A). GTC administration 
caused significant body weight reduction (about 9.4% and 
6.3% compared to corresponding control groups) in both the 
HF and CHOW groups within 30 d (Figure 1B). This effect 
became more obvious (about 11.8% and 8.2%) after 45 d of 
GTC feeding (Figure 1C). GTCs also significantly reduced 
the ratios of liver to body weight and the TG contents in the 
livers and blood plasma (Figure 1D–G). Moreover, lipid 
peroxidation was decreased in the livers of rats fed GTCs 
(Figure 1H).  
2.2  GTCs have opposite effects on PPAR expression 
in SWAT and VWAT 
PPAR is one of the central regulators of adipogenesis that 
promotes lipid storage in adipocytes [14]. GTCs increased 
the PPAR level in subcutaneous white adipose tissue 
(SWAT) in both the HF (about 50.2%) and CHOW (about 
39.8%) groups (Figure 2A and A1). However, GTCs de-
creased the levels of PPAR in visceral (mesentery) white 
adipose tissue (VWAT) in both the HF (about 23.1%) and 
CHOW (about 18.7%) groups (Figure 2B and B1).  
2.3  GTCs up-regulate the expression of PPAR and its 
down-stream genes in adipose tissues 
In contrast to PPAR, PPAR stimulates -oxidation of fat 
and utilization of triglycerides [16]. Our results showed that 
administration of GTCs consistently increased PPAR lev-
els in all types of adipose tissues tested. For BAT, PPAR 
level increased about 23.2% in the HF group and 19.7% in 
the CHOW group. For SWAT, PPAR level increased 
about 80.1% in the HF group and 39.6% in the CHOW 
group. For VWAT, PPAR level increased about 52.4% in 
the HF group and 37.3 % in the CHOW group (Figure 3A 
and A1). The expression of UCP-1, a marker for BAT, was 
also increased in SWAT and VWAT (Figure 3B and B1) 
after GTC treatment. To further examine the effect of GTCs 
on PPAR-mediated signaling, we studied the expression of 
the PPAR down-stream target genes, carnitine palmito-
yltransferase-1 (CPT1), acyl-CoA oxidase (AOX), and UCP-1, 
in BAT. We found that GTCs significantly increased the 
expression of CPT1, AOX, and UCP-1. For CPT1, expres-
sion increased about 27.4% in the HF group and 50.8% in 
the CHOW group (Figure 3C and C1). For AOX, expres-
sion increased about 42.7% in the HF group and 62.9% in 
the CHOW group (Figure 3C and C2). For UCP-1, expres-
sion increased about 19.7% in the HF group and 21.1% in 
the CHOW group (Figure 3C and C3). 
3  Discussion 
In this study, we investigated the anti-obesity and hypoli-
pidemic mechanisms of GTCs (100 mg1 kg1 d1) using a 
rat model of HF diet-induced obesity. Our results showed 
that GTCs significantly reduced the body weight of rats after 
30 d. The differences between GTCs and control groups 
became more obvious after GTCs were given to the rats for 
45 d, indicating more weight loss can be achieved when 
GTCs are given for an extended period. Weight manage-
ment is difficult and even a moderate level of weight loss 
can be beneficial for conditions such as hypertension and 
T2DM [21]. Therefore, it is impressive that GTC supple-
mentation can cause such rapid weight loss in overweight 
rats. The decreased body weight in the rats fed the normal 
chow diet and GTCs suggests that drinking green tea may 
be beneficial for maintaining healthy weight in the general 
population. GTCs also decreased blood and liver lipids,  
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Figure 1  Anti-obesity and hypolipidemic effects of GTCs. A, Photographs of representative rat fed with or without GTCs for 45 d in the high-fat diet 
group. B and C, Body weights of CHOW (chow diet group), CHOW+GTCs (chow diet+GTCs group), HF (high-fat diet control group) and HF+GTCs 
(high-fat diet+GTCs group) after feeding with GTCs 100 mg kg1 (body weight) d1 or water for 30 d (B) or 45 d (C) (n=8; #, P<0.05 vs. HF; *, P<0.05 vs. 
CHOW). D, Photographs of the representative livers from rats fed with or without GTCs for 45 d. E, GTCs reduced the liver to body weight ratios in both 
HF (#, P<0.05) and CHOW (*, P<0.05) groups. F, GTCs reduced liver triglyceride contents in both HF (#, P<0.05) and CHOW (*, P<0.01) groups. G, 
GTCs reduced serum triglyceride contents in both HF (#, P<0.01) and CHOW (*, P<0.01) groups. H, GTCs reduced liver TBARS levels in both HF (#, 
P<0.01) and CHOW (*, P<0.01) groups. 
 
which are directly related to fatty liver and atherosclerosis. 
By lowering the lipids stored in the liver and circulated in 
the blood, administration of GTCs is likely to inhibit the 
pathogenesis of these diseases. 
Food intake by rats has been shown to be reduced by the 
treatment of EGCG and is proposed to contribute to the 
weight-loss effect of EGCG [22]. In contrast, there are also 
reports claiming that supplementation with green tea or 
GTCs does not significantly affect food consumption [4,23]. 
These discrepancies may be caused by different supple-
mentation methods and concentrations of GTCs. In our ex-
periments, we found that the food intake of the rats fed 
GTCs was not significantly different compared to the rats 
fed the control diet (P>0.1). Therefore, mechanisms other 
than a decrease in food intake were involved in the anti-     
obesity effects of GTCs.  
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Figure 2  Effects of GTCs on the expression of PPAR in subcutaneous white adipose tissue (SWAT) (A) and visceral white adipose tissue (VWAT) (B). 
Rats were fed different diets for 45 d and the adipose tissue samples were analyzed by Western blot. The intensities of the bands were quantified by densito-
metric analysis and the results (A1 and B1) are expressed as fold changes by normalizing the data to the values obtained from the CHOW diet group, which 
were set to 1.0 (n=6; #, P<0.01 vs. HF; *, P<0.01 vs. CHOW). 
 
We found that GTCs might exert anti-obesity effects 
through PPAR pathways. First, our results showed that 
GTCs had distinct effects on the levels of PPAR in differ-
ent types of adipose tissue. GTCs increased the PPAR level 
in SWAT and decreased the PPAR level in VWAT. In 
VWAT, the decreased PPAR level and decreased fat con-
tent indicated that the fat accumulation in this tissue was 
inhibited by the GTC treatment. In SWAT, the increased 
PPAR level might promote the adipogenesis and lipid 
storage functions of SWAT. Therefore, fewer lipids would 
be stored in other tissues such as VWAT, liver, and blood, 
as shown in our results. Because improving the lipid meta-
bolic functions of SWAT is an important strategy for the 
therapy of T2DM and other linked metabolic disorders [24], 
drinking green tea or supplementation of GTCs could be 
beneficial for patients with these diseases. 
In addition to modulating the fat distribution in different 
adipose tissue, total lipid mass in the body could also be 
reduced by GTC treatment. We found that GTCs increased 
PPAR levels in both BAT and WAT. In addition, the ex-
pressions of PPAR down-stream genes such as AOX, 
CPT1, and UCP-1 were increased. Since BAT is the major 
thermogenic tissue [15], the increased protein level of 
PPAR in BAT suggests the promotion of -oxidation in 
BAT by GTCs. UCP-1 is the marker gene of brown adipo-
cytes. Therefore, the up-regulation of UCP-1 in VWAT and 
SWAT by GTCs suggests that the white adipocytes might 
have acquired the features of brown adipocytes [25]. When 
WAT acquires BAT features, fatty acid oxidation and ener-
gy uncoupling are increased [25,26]. Taken together, GTCs 
increased the energy expenditure of adipocytes and reduced 
the total mass of lipids in the body possibly by stimulating 
the function of BAT and promoting BAT features in WAT. 
PPAR enhances lipid consumption in the liver by up-    
regulating genes encoding enzymes in -oxidation. Green 
tea but not EGCG supplementation was found to upregu-
late the expression of PPAR in livers of rats [23,27]. In 
contrast, our results did not show an upregulation of 
PPAR expression in the livers of the rats fed GTCs (data 
not shown). Previously, it was reported that green tea and 
its main component EGCG increased the activation of 
PPAR in COS-1 cells [19]. Thus, future studies on GTCs’ 
effects need to explore the expression and activation of 
PPAR. 
Our results show that GTCs exert their anti-obesity 
mechanisms in part by modulating PPAR pathways. How-
ever, other mechanisms underlying the anti-obesity effects 
of GTCs cannot be excluded. GTCs can scavenge free radi-
cals as antioxidants [28–31]. Moreover, oxidative stress is 
associated with adiposity in both human and mouse models 
of obesity [32–34]. Thus, GTCs may prevent obesity by 
restoring the antioxidative potential of the tissue. In addition, 
GTCs can bind to digestive enzymes, including glucosidas-
es and lipases [35], and it is possible that they prevent the 
digestion and absorption of carbohydrates and lipids in the 
animals. This would decrease the calories absorbed even if 
the food intake by animals was not affected in the experi-
ment. 
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Figure 3  GTCs increased the expression of PPAR and activated PPAR pathway of beta oxidation and energy uncoupling in adipose tissues. Rats were 
fed different diets for 45 d and the adipose tissue samples were prepared. A, Levels of PPAR in BAT, SWAT, and VWAT analyzed by Western blot. B, 
mRNA levels of UCP-1 in SWAT and VWAT analyzed by RT-PCR. C, mRNA levels of CPT1, AOX, and UCP-1 in BAT analyzed by RT-PCR. The inten-
sities of the bands were quantified by densitometric analysis and the results (A1, B1, C1, C2, C3) are expressed as fold changes by normalizing the data to 
the values obtained from the CHOW diet group, which were set to 1.0 (n=6; #, P<0.01 vs. HF; *, P<0.01 vs. CHOW). C1, CPT1; C2, AOX; C3, UCP-1. 
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